Novartis is committed to transforming the lives of people living with blood cancers and serious blood disorders.
Novartis joins seven global companies to found the Value Balancing Alliance
Novartis announced the company’s financial results for the second quarter and first half of 2019.
Novartis transforms its Global Health & Corporate Responsibility organization.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.